Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Application

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to 21 CFR 1301.33(a), this is a notice that on June 10, 2004 Aldrich Chemical Company Inc., DBA Isotec, 3858 Benner Road, Miamisburg, Ohio 45342-4304, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed:

DrugSchedule
Cathinone (1235)I
Methcathinone (1237)I
N-Ethylamphetamine (1475)I
N,N-Dimethylamphetamine (1480)I
Aminorex (1585)I
Gamma hydroxybutyric acid (2010)I
Methaqualone (2565)I
Lysergic acid dethylamide (7315)I
Tetrahydrocannabinols (7370)I
Mescaline (7381)I
2,5-Dimethoxyamophetamine (7396)I
3,4-Methylenedioxyamphetamine (7400)I
3,4-Methylenedioxy-N-ethylamphetamine (7404)I
3,4-Methylenedioxy-methamphetamine (7405)I
4-Methoxyamphetamine (7411)I
Psilocybin (7437)I
Psilocyn (7438)I
N-Ethyl-1-phenylcyclohexalamine (7455)I
Dihydromorphine (9145)I
Normorphine (9313)I
Acetylmethadol (9601)I
Alphacetylmethadol Except Levo-Alphacetylmethadol (9603)I
Normethadone (9635)I
3-Methylfentanyl (9813)I
Amphetamine (1100)II
Methamphetamine (1105)II
Methylphenidate (1724)II
Amobarbital (2125)II
Pentobarbital (2270)II
Secobarbital (2315)II
1-Phenylcyclohexalamine (7460)II
Phencyclidine (7471)II
Phenylacetone (8501)II
1-Piperidinocyclohexane-carbonitrile (8603)II
Codeine (9050)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Benzoylecgonine (9180)II
Ethylmorphine (9190)II
Hydrocodone (9193)II
Isomethadone (9226)II
Meperidine (9230)II
Meperidine intermediate-A (9232)II
Meperidine intermediate-B (9233)II
Methadone (9250)II
Methadone intermediate (9254)II
Dextropropoxyphene, bulk, (non-dosage forms) (9273)II
Levo-alphacetylmethadol (9648)II
Oxymorphone (9652)II
Fentanyl (9801)II

The company plans to manufacture small quantities of the listed controlled substances to produce isotope labeled standards for drug analysis.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCD) and must be filed no later than (60 days from publication).

Start Signature

Dated: September 16, 2004.

William J. Walker,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 04-21944 Filed 9-29-04; 8:45 am]

BILLING CODE 4410-09-M